We hypothesized that DC12 could improve liver function, which is counteracting the effects of a high‐fat diet (HFD) that causes metabolic dysfunction‐associated steatohepatitis (MASH) in rodents by inhibiting the citrate/Na+ symporter, highly active in hepatocytes. This evidence concerns the gene HMCES and metabolic dysfunction-associated steatohepatitis.